Letizia Bettelini

6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor

Fabrizio Micheli, Paolo Cavanni, Daniele Andreotti et al. · Journal of Medicinal Chemistry · 2010 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse

Alessandro Zocchi, Giorgia Varnier, Roberto Arban et al. · Neuroscience Letters · 2003 · 63 citations

Medicine, Neuroscience, Pharmacology +17

1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors

Fabrizio Micheli, Paolo Cavanni, Roberto Arban et al. · Journal of Medicinal Chemistry · 2010 · 51 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9

Potent Antihyperalgesic Activity without Tolerance Produced by Glycine Site Antagonist of N-Methyl-d-Aspartate Receptor GV196771A

M. Quartaroli, Corrado Carignani, Giovanna Dal Forno et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 50 citations

Life Sciences, Neuroscience, Pharmacology +17

Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity

Lee A. Dawson, Zoë A. Hughes, Kathryn R. Starr et al. · Neuropharmacology · 2006 · 40 citations

Medicine, Neuroscience, Pharmacology +16